GMP change control is the formal, documented system that manufacturers in regulated industries use to propose, evaluate, approve, implement, and review any change that could affect product quality, safety, or compliance. [1] ICH Q10 defines the underlying activity as 'a systematic approach to proposing, evaluating, approving, implementing and reviewing changes,' and names a change management system as one of the core elements of a pharmaceutical quality system. [1] It governs changes to processes, equipment, materials, suppliers, analytical methods, specifications, computerized systems, and the controlling documents themselves, including SOPs. [4] The defining principle is that nothing changes quietly: a change is evaluated against risk before it happens, approved by the quality unit, and checked afterward to confirm it did what it was meant to do without harming product quality. [1] [2]
Key characteristics
- Formal and documented, not ad hoc: every change is proposed, evaluated, approved, implemented, and reviewed through one system. [1]
- Risk-based: the depth and formality of the evaluation scale with the level of risk, using the quality risk management methods of ICH Q9. [1]
- Prospective: planned changes must be assessed and approved before they are implemented, not after the fact. [2]
- Verified afterward: an effectiveness check confirms the change met its objective with no deleterious impact on product quality. [1] [2]
- Quality-unit governed: under US cGMP, written procedures and any changes to them must be reviewed and approved by the quality control unit. [3]
Example
Changing a tablet coating SOP at a contract manufacturer
A pharmaceutical contract manufacturer wants to raise the spray rate on a tablet coating line. Because the change could affect the product, it cannot just be done. A change request is raised, a cross-functional team (production, quality, regulatory) runs a risk assessment, and the change is approved before any batch runs. The coating SOP is updated to the new parameters, operators on every shift are retrained on the new version, and the first batches are checked to confirm the change achieved its goal with no impact on quality. Only then is the change closed. The updated SOP, the approval trail, and the proof that operators were trained on the new version are all part of the record.
Comparison
Change control vs deviation
| Aspect | Change control | Deviation |
|---|---|---|
| Timing | Planned, before the change happens | Unplanned, after work went off-procedure |
| Trigger | A deliberate improvement or required change | A departure from the written procedure |
| Regulatory basis | 21 CFR 211.100(a), EU GMP Ch.1, ICH Q10 | 21 CFR 211.100(b): deviations recorded and justified |
| Outcome | Approved, implemented, verified, closed | Investigated, root-caused, often feeds CAPA |
How SOPX handles this
SOPX is not a full quality-management change-control suite, but it covers the part of change control where most teams lose the thread: getting the revised procedure in front of the people who do the work, and proving they followed it. When a change is approved, a supervisor updates the procedure, the previous version is preserved in history (Pro supports version restore), and Run mode captures each operator confirming, with a signature, that they executed the new steps. Analytics show who viewed and ran the latest version. The formal risk assessment and approval still live in your quality system, but the document and the retraining evidence stay current and traceable.
Related use case: Quality & Compliance →Frequently asked questions
What is the difference between change control and change management?
What triggers a GMP change control?
What is the difference between a change and a deviation?
What is an effectiveness check?
Does updating an SOP need change control?
Sources
Statements above draw on the references below. Numbers in the text link to the matching entry.
- [1]ICH Q10 Pharmaceutical Quality SystemICH (International Council for Harmonisation) · Accessed 2026-06-20
- [2]EudraLex Volume 4, EU GMP Guide, Chapter 1: Pharmaceutical Quality SystemEuropean Commission · Accessed 2026-06-20
- [3]21 CFR 211.100 - Written procedures; deviationsCornell Law School, Legal Information Institute · Accessed 2026-06-20
- [4]Change Control in Pharma: Definition, Types, Process, and Regulatory RequirementsSimplerQMS · Accessed 2026-06-20